Ignite Creation Date:
2024-05-06 @ 6:41 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05745623
Status:
RECRUITING
Last Update Posted:
2023-02-27
First Post:
2023-02-16
Brief Title:
A Phase 2 Study of ICP-723 in Patients With Advanced Solid Tumors or Primary Central Nervous System Tumors
Sponsor:
Beijing InnoCare Pharma Tech Co Ltd
Organization:
Beijing InnoCare Pharma Tech Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-12-27
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-16
First Submit QC Date:
February 16 2023
Study First Post Date:
2023-02-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-16
Last Update Post Date:
2023-02-27
Last Update Post Date Type:
ACTUAL